₹ 71.11
-1.61 (-2.21%)
BSE
C
Concord Drugs
₹ 71.11
BSE
Concord Drugs Fundamentals
Company Valuation
Market Cap (₹ Cr.)
94
PE Ratio
46.60
PB Ratio
2.05
Dividend Yield
-
ROE
2.17%
ROCE
5.92%
Book Value (₹)
35.43
Face Value (₹)
10.00
Analyse CONCORD with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Nov 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|
| Promoters | 45.08% | 54.39% | 54.39% | 45.08% | 45.08% |
| Domestic Institutional Investors (DII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Foreign Institutional Investors (FII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Investors | 54.43% | 44.96% | 44.66% | 54.19% | 54.29% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
CONCORD Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals & Biotechnology
Company Classification
Microcap
BSE Scrip Code
538965
NSE Scrip Name
CONCORD
ISIN
INE858L01010

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App






